Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Evolution of nanobodies specific for BCL11A
Maolu Yin, Manizheh Izadi, Karin Tenglin, et al.
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 3
Open Access | Times Cited: 22

Showing 22 citing articles:

In vivo neutralization of coral snake venoms with an oligoclonal nanobody mixture in a murine challenge model
Melisa Bénard-Valle, Yessica Wouters, Anne Ljungars, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 11
Chromatin remodellers as therapeutic targets
Hayden A. Malone, Charles W.M. Roberts
Nature Reviews Drug Discovery (2024) Vol. 23, Iss. 9, pp. 661-681
Closed Access | Times Cited: 10
Opportunities and challenges of protein-based targeted protein degradation
Fangfang Shen, Laura M. K. Dassama
Chemical Science (2023) Vol. 14, Iss. 32, pp. 8433-8447
Open Access | Times Cited: 22
Transcriptional Repressor BCL11A in Erythroid Cells
Zheng Ge, Stuart H. Orkin
Advances in experimental medicine and biology (2024), pp. 199-215
Closed Access | Times Cited: 6
Beyond canonical PROTAC: biological targeted protein degradation (bioTPD)
Huifang Wang, Runhua Zhou, Fushan Xu, et al.
Biomaterials Research (2023) Vol. 27, Iss. 1
Open Access | Times Cited: 14
Nanobody engineering: computational modelling and design for biomedical and therapeutic applications
Nehad S. El Salamouni, Jordan H. Cater, Lisanne M. Spenkelink, et al.
FEBS Open Bio (2024) Vol. 15, Iss. 2, pp. 236-253
Open Access | Times Cited: 5
Discovery of SOCS7 as a versatile E3 ligase for protein-based degraders
Anaïs Cornebois, Marie Sorbara, Margot Cristol, et al.
iScience (2024) Vol. 27, Iss. 5, pp. 109802-109802
Open Access | Times Cited: 4
Structural insights into the DNA-binding mechanism of BCL11A: The integral role of ZnF6
Thibault Viennet, Maolu Yin, Abhilash Jayaraj, et al.
Structure (2024)
Open Access | Times Cited: 4
Protein-Based Degraders: From Chemical Biology Tools to Neo-Therapeutics
Lisha Ou, Mekedlawit Setegne, Jeandele Elliot, et al.
Chemical Reviews (2025)
Closed Access
Hemoglobin Variants as Targets for Stabilizing Drugs
Miroslava Žoldáková, Michal Novotný, Krishna P. Khakurel, et al.
Molecules (2025) Vol. 30, Iss. 2, pp. 385-385
Open Access
Solution structure of the Z0 domain from transcription repressor BCL11A sheds light on the sequence properties of protein‐binding zinc fingers
R. Harris, Richard D. Whitehead, Andrei T. Alexandrescu
Protein Science (2025) Vol. 34, Iss. 4
Closed Access
Development of nanobodies specific to clumping factors A of Staphylococcus aureus by yeast surface display
Meng Mei, Mengqing Lu, Shiqi Li, et al.
International Journal of Biological Macromolecules (2024) Vol. 259, pp. 129208-129208
Closed Access | Times Cited: 3
Base editing of key residues in the BCL11A-XL-specific zinc finger domains derepresses fetal globin expression
Vignesh Rajendiran, Nivedhitha Devaraju, Mahdi Haddad, et al.
Molecular Therapy (2024) Vol. 32, Iss. 3, pp. 663-677
Open Access | Times Cited: 2
Engineered polyspecific antibodies: A new frontier in the field of immunotherapeutics
Sandeep Sherawat, Suraj H. Shinde, Sakeel Ahmed, et al.
Immunology (2023) Vol. 171, Iss. 4, pp. 464-496
Open Access | Times Cited: 5
Structural Insights into the DNA-Binding Mechanism of BCL11A: The Integral Role of ZnF6
Thibault Viennet, Maolu Yin, Abhilash Jayaraj, et al.
(2024)
Open Access | Times Cited: 1
Nanobody Engineering: Computational Modelling and Design for Biomedical and Therapeutic Applications
Nehad El Salamouni, Jordan H. Cater, Lisanne Spenkelink, et al.
(2024)
Open Access | Times Cited: 1
Nanobody Engineering: Computational Modelling and Design for Biomedical and Therapeutic Applications
Nehad El Salamouni, Jordan H. Cater, Lisanne Spenkelink, et al.
(2024)
Open Access | Times Cited: 1
Gold nanoparticle-based lateral flow immunoassay for the repaid and sensitive detection of pyraclostrobin in wheat, apple, Chinese cabbage, and soil samples
Tianyang You, Zhiying Zhang, Jinyu Ma, et al.
Journal of Food Composition and Analysis (2024) Vol. 134, pp. 106551-106551
Closed Access | Times Cited: 1
Structural Insights into the DNA-Binding Mechanism of BCL11A: The Integral Role of ZnF6
Thibault Viennet, Maolu Yin, Abhilash Jayaraj, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Linking Protein Stability to Pathogenicity: Predicting Clinical Significance of Single-Missense Mutations in Ocular Proteins Using Machine Learning
Iyad Majid, Yuri V. Sergeev
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 21, pp. 11649-11649
Open Access
Redirecting E3 Ubiquitin Ligases for Targeted Protein Degradation with Heterologous Recognition Domains
Huan Yang, Ge Zheng, Grace Y. Li, et al.
Journal of Biological Chemistry (2024), pp. 108077-108077
Open Access
Solution structure of the Z0 domain from transcription repressor BCL11A sheds light on the sequence properties of protein-binding zinc-fingers
R. Harris, Richard D. Whitehead, Andrei T. Alexandrescu
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Page 1

Scroll to top